Cell line · CVCL_5423
Papers99
1 to 20 of 99
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Survival of cancer cells following taxol-induced apoptosis is supported by ZEB1-mediated ferroptosis sensitivity. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Partial Loss of FITM2 Function Causes Hereditary Spastic Paraplegia. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Structural Mechanisms of DNAJC13 Dimeric Assembly and InsP6 binding in Recycling Endosome Regulation. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Collagen-Binding IL-15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self-Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immunity. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bioinformatic Identification and Experimental Validation of a Prognostic Transcriptional Signature Derived from Asparagine Metabolism-Related Genes in Breast Cancer. | Biology (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Stromal Laminin Subunit Alpha 3 is a Novel Prognostic Marker for Breast Cancer. | Clin Med Insights Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intratumoral Hypoxia Triggers Mitochondrial BHLHE40 ROS Sensing Pathway to Promote Radioresistance in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| YIF1A activates mTORC1 signaling to promote cellular senescence. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation. | Clin Exp Metastasis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ribosome biogenesis bottlenecks reveal vulnerabilities in cancer. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Repurposing Quetiapine as an Adjuvant Therapeutic Agent for Triple-Negative Breast Cancer. | Radiat Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor-Intrinsic PD-L1 Promotes Breast Cancer Proliferation Through Livin and Galectin-1-Mediated Regulation of SKP2 Expression. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| 3D "Emboli" Culture Models Epithelial Breast Cancer Cell Oxidative Mitochondrial Metabolism with Relevance for Lung Metastasis. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Three-Dimensional Tumor Spheroids Reveal B7-H3 CAR T Cell Infiltration Dynamics and Microenvironment-Induced Functional Reprogramming in Solid Tumors. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed | |
| piR-1170 drives brain metastasis and immune evasion via WTAP-mediated m6A methylation reprogramming in triple-negative breast cancer. | Mol Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lipid Droplet-Localized Spindle Apparatus Coiled-Coil Protein 1 Regulates Lipid Droplet Distribution. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer. | Cancers (Basel) | 2025 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_5423/papers